The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).
 
Benjamin Avi Derman
Honoraria - Multiple Myeloma Research Foundation; OncLive/MJH Life Sciences; Plexus
Consulting or Advisory Role - Cota Healthcare; Gerson Lehrman Group; Guidepoint Global; Janssen Scientific Affairs; PRECISIONHeor; Sanofi
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene
 
Jennifer H. Cooperrider
Employment - Abbvie (I)
Stock and Other Ownership Interests - Abbvie (I)
 
Tadeusz Kubicki
No Relationships to Disclose
 
Ajay Major
No Relationships to Disclose
 
Ken Jiang
No Relationships to Disclose
 
Aubrianna Ramsland
No Relationships to Disclose
 
Karson Buckley
No Relationships to Disclose
 
Samrawit Melka
No Relationships to Disclose
 
Amanda McIver
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi